The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. Until today this year the stock’s price performance recorded an increase of 26.32%. However, over the last six months, the performance has been weaker by 27.27%. The price of ATAI increased 7.69% over the last 30 days. And in the last five days, it has surged by 26.32%.
The stock market performance of ATAI Life Sciences N.V has been fairly unsteady. Over the last year, the company’s stock hit its highest at $2.85 on 04/04/24, while the lowest price during the same time frame was $1.03, recorded on 10/11/24.
52-week price history of ATAI Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. ATAI Life Sciences N.V’s current trading price is -41.05% away from its 52-week high, while its distance from the 52-week low is 63.11%. The stock’s price range for this period has been between $1.03 and $2.85. The Healthcare sector company’s shares saw a trading volume of about 1.36 million for the day, which was lower than the average daily volume of 1.6 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
ATAI Life Sciences N.V (ATAI) has experienced a quarterly rise of 48.67% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 281.90M and boasts a workforce of 83 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.3233, with a change in price of +0.4350. Similarly, ATAI Life Sciences N.V recorded 1,211,371 in trading volume during the last 100 days, posting a change of +34.80%.
ATAI’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for ATAI stands at 0.16. Similarly, the long-term debt-to-equity ratio is also 0.15.
ATAI Stock Stochastic Average
As of today, the raw stochastic average of ATAI Life Sciences N.V over the last 50 days is at 70.88%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 70.39%. Further, the company’s Stochastic %K and %D values for the last 20 days were 77.45% and 84.51%, respectively.
